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An Asn to Asp exchange in position two is shown to be one sequence difference between the two major isoelectric variants 
of the catalytic subunit (C) of the CAMPdependent protein kinase from bovine heart, Cr r, representing the main and 
sequenced form, and Cr.,, a variant form ](1989), Biochem. Biophys. Res. Commun. 160,596601]. 
Protein kinase; Cyclic AMP, [Bovine) 
1. INTRODUCTION 
The CAMP-dependent protein kinase, consisting 
of two regulatory and two catalytic subunits, 
represents a key element in a number of metabolic 
cascades which are under hormonal control (for 
review see [l-3]). It has been shown that more 
than four stable isoelectric forms of the catalytic 
subunit (C) exist in bovine cardiac muscle [4]. The 
variants focusing at pH 7.1 and 7.5 (named (27.1 
and C7.5) represent the predominant part of the 
peaks CA and CB, respectively, as separated from 
homogeneous enzyme preparations by ion ex- 
change chromatography [5]. The forms CA and Ca 
have also been observed in enzyme preparations 
isolated by other laboratories according to stan- 
dard procedures [5,6]. The form (27.5 appears to 
represent the enzyme first sequenced 171. To date 
two mRNA forms, C, and Ca, have been 
discovered [8,9]. In searching for possible se- 
quence differences between C7.1 and (27.5, cleavage 
of both variants by Asp-N protease [lo] was 
chosen followed by sequencing of selected peptide 
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fragments. The data indicate a sequence difference 
between both forms at the N-terminus. 
2. MATERIALS AND METHODS 
Immobilines were from Pharmacia/LKB (Freiburg, FRG), 
endoproteinase Asp-N, sequencing rade, was from Boehringer 
Mannheim (FRG), triffuoroacetic acid was from Pierce/Faust 
GmbH (K&r, FRG), acetonitrile was from Zinsser (Frankfurt, 
FRG), sequencing chemicals were from Applied Biosystems 
(Weiterstadt, FRG/Foster City, CA, USA). 
The separation of the isoforms of the catalytic subunit of the 
CAMP-dependent protein kinase prepared from bovine heart in 
high resohrtion immobiline gels was carried out as described 141. 
The bands visible without staining were cut out from the gel and 
eluted with 1 M tris-(hydroxymethyl)-aminomethane, 0. I % 
EDTA, 0.12 M 2-mercaptoethanol pH 8.6. 
The alkylation of the catalytic subunit isoforms and the 
cleavage by Asp-N protease were carried out essentially accord- 
ing to [lo] with modifications. Nine volumes of the catalytic 
subunit protein in dution buffer were combined with one 
volume of 1.2 M iodoacetic acid in the same buffer. After 
IS min in the dark the reaction was stopped with 15 pl of 
2-mercaptoethanol per 100 pl iodoacetic acid. After dialysis 
against 0.1 M ammonium bicarbonate pH 7.8,2 pg Asp-N pro- 
tease per 200 cg of protein were added. The digestion proceeded 
for 16 h at 36°C. The peptides were separated by HPLC on a 
Cl%-p-Bondapak cofumn (Waters, 300 mm, 0 4 mm). The 
starting buffer was 0.1% trifluoroacetic acid, buffer B was 60% 
acetonitrile in 0.1% trifhtoroacetic acid and the flow rate was 
1 ml/min. The gradient was O-70% buffer B in 70 min, 
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70-100% buffer B in 15 min at 25’C. The peptides were 
monitored at 206 nm. 
Sequencing was done with an Applied Biosystems 470A se- 
quencer equipped with a model 120A PTH online analyzer. 
3. RESULTS AND DISCUSSION 
The two major isoelectric forms of the catalytic 
subunit of the CAMP-dependent protein kinase 
focusing at pH 7.1 and 7.5 (C.1 and C,J) [4] were 
cleaved by the Asp-N protease and the resulting 
peptides were separated by reversed-phase 
chromatography. The elution profiles are shown in 
fig. 1. While most of the peptide peaks have the 
same position in both profiles, one peak at 43% 
buffer B appears in C7.1 only and one peak at 73% 
buffer B appears in C7.5 only. These different 
peaks are marked by asterisks. Sequencing of the 
marked peak in C7.5 yielded no detectable 
phenylthiohydantoin (PTH). The marked peak in 
C7.1 showed an Asp at the first position followed 
by the amino acids of positions 3-24 of the se- 
quenced bovine enzyme [7]. The regression curve 
of the yields of the PTH amino acids is shown in 
fig.2, demonstrating that the peptide was sequenc- 
ed with an average repetitive yield of more than 
90%. The N-terminus of C7.1 is blocked, possibly 
by myristic acid [I 11. The yet unknown blocking 
group and the first amino acid Gly seem to be 
removed by the Asp-N protease in the case of C7.1 
because of an exchange from Asn to Asp at posi- 
tion 2. The same result was also obtained in a 
preliminary experiment with CA [5] which consists 
mainly of C7.r [4] (data not shown). The original 
N-terminal peptide is expected to elute last from 
the reversed phase column because of the fatty 
acid. The marked peptide in the C7.5 profile 
represents the original N-terminal peptide which 
cannot be sequenced because of the blocking 
group. This was proven by subsequent cleavage of 
the marked peptide by V8 protease and sequencing 
of the cleavage products (data not shown). Other 
peptides from both variants, as listed in table 1, 
have been sequenced without revealing differences 
to the published sequence [7]. The isoelectric point 
of C7.r is 0.4 pH units more acidic than the main 
form, a difference to which the Asn to Asp muta- 
tion contributes; however, in spite of the similarity 
of the HPLC patterns, there may be additional dif- 
ferences between the two forms. 
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Fig. 1. Peptide pattern of C7.r and C7.s cleaved by 
endoproteinase Asp-N. The dotted line indicates the 
concentration of buffer B (60% acetonitrile, 0.1% 
trifluoroacetic acid). 
The Asn to Asp exchange does not appear to 
result from deamidation. Transglutaminases, 
which can deamidate Gin to Glu in proteins, do 
not seem to act on Asn [12]. Nonenzymatic 
deamidation appears to be very unlikely (a) 
because the change of only one Asn out of seven 
sequenced is very specific, (b) because of the rather 
mild conditions of the preparation (pH 6-7), and 
the facts that (c) various methods including those 
standardly used in other laboratories yielded the 
isoenzymes [5,6], (d) the proportions of C7.i to 
C7.5 are reproducible, and (e) the isoelectric points 
of each form remain the same upon 
rechromatography [4,5]. 
On the nucleic acid level this exchange would re- 
quire an A to G point mutation. The C, gene is 
known to consist of several exons and introns [ 131. 
There is no indication of an alternative splicing site 
responsible for this exchange. Thus, a second C, 
gene or an allele has to be postulated, but so far 
has not been detected. 
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Fig.2. Regression curve of the yields of the PTH amino acids 
of peak * (C7.1). Amino acids are given in the one letter code, 
yields are in pmol (o). The values for Ser and the C-terminal 
Glu (0) were omitted in calculating the regression curve. 
The exchange in position 2 is not conservative 
and is therefore likely to cause structural dif- 
ferences in the N-terminal part of the molecule. 
The function of this part of the catalytic subunit 
has not been determined. In contrast to the src 
kinase, the myristic acid and the first amino acids 
are not necessary for kinase activity as shown in 
cells overexpressing a catalytic subunit with a 
modified N-terminus 1141. Therefore C7.i may dif- 
fer from the main form in its intracellular localiza- 
tion and in nucIear transfer [lSJ as a physiofogical 
consequence of this exchange. This difference 
would probably influence the capability of C7.1 to 
regulate the transcription of genes. 
REFERENCES 
VI 
PI 
I31 
Nimmo, H.G. and Cohen, P. (1977) Adv. Cycl. 
Nucleotide Res. 8, 256-275. 
Krebs, E.G. and Beavo, J.A. (1977) Annu. Rev. Biochem. 
48, 923-959. 
Flockart, D.A. and Corbin, J.D. (1982) CRC Crit. Rev. 
Biochem. 12, 133-186. 
October 1989 
Table 1 
Identified peptides of C7.r and C7.s 
Peak Sequenceb Position in 
no. sequence [7] 
1 DQPIQIY 241-247 
la DKQKVVKLKQIEHTLN 75- 90 
2 DIKNHKWFATT 290-300 
*c7. I DAAAAKKGSEQESVKEFLAKAKE 2- 24 
3 DFLKKWENPAQNTAHL 25- 40 
4 DYEEEEIRVSINEKCGKEFSEF 329-350 
4” DWIAIYQRKVEAPFIPKFKGPG 301-322 
*C?.S N-terminally blocked N-terminus 
a Mixture of two peptides in one peak, sequenced as mixture 
b Identical to the published sequence [7] except for an Asn to 
Asp exchange in the first residue of *C7,r 
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